Prana Announces Successful Phase 2 Results in Huntington Disease Trial February 18, 2014August 16, 2022
Alterity Therapeutics Announces Granting of New Composition of Matter Patent and Exclusive License Agreement for Assets in Alzheimer’s Disease March 14, 2023May 23, 2023